Pfizer-BioNTech agree to supply WHO co-led Covid-19 vaccine scheme: Report

Pfizer and BioNTech have agreed to supply their Covid-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two sources familiar with the deal said, the latest in a series of shots to be included in the project aimed at lower-income countries.
 

The deal is expected to be announced on Friday, according to the sources, who declined to be named due to the confidentiality of the agreement.
 

Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small. One